Almoosa Health Company (TADAWUL:4018)

Saudi Arabia · Delayed Price · Currency is SAR

118.80

-0.40 (-0.34%)

Jul 2, 2026, 3:17 PM AST

-26.03% (1Y)

Market Cap	5.26B -22.5%
Revenue (ttm)	1.44B +15.5%
Net Income	192.84M +87.5%
EPS	4.35 +57.3%
Shares Out	44.30M
PE Ratio	27.30
Forward PE	23.48
Dividend	1.40 (1.18%)
Ex-Dividend Date	May 18, 2026

Volume	13,543
Open	118.90
Previous Close	119.20
Day's Range	117.40 - 119.40
52-Week Range	110.00 - 212.00
Beta	n/a
Analysts	Hold
Price Target	165.13 (+39.0%)
Earnings Date	Aug 3, 2026

About Almoosa Health Company

Almoosa Health Company operates as a private healthcare provider in the Kingdom of Saudi Arabia. It stores medical items and sells medicine, cosmetics, and disposable medical items. The company also operates specialist and rehabilitation hospitals, medical and emergency centers, pharmacies, mental health clinics, and oncology centers, as well as a college of health sciences. Its medical specialties include pain management, lymphatic massage, hyperbaric oxygen therapy, occupational therapy, speech and language disorders, personality and behavior... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1996

Employees 2,884

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4018

Full Company Profile

Financial Performance

In 2025, Almoosa Health Company's revenue was 1.42 billion, an increase of 17.79% compared to the previous year's 1.20 billion. Earnings were 236.54 million, an increase of 379.28%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 4018 stock is "Hold." The 12-month stock price target is SAR 165.13, which is an increase of 39.00% from the latest price.

Price Target

SAR 165.13

(39.00% upside)

Analyst Consensus: Hold

Stock Forecasts